Suppr超能文献

血清miR-17-5p在2型糖尿病中的诊断价值及其对慢性并发症的预测价值

Diagnostic Value of Serum miR-17-5p in Type 2 Diabetes Mellitus and Its Predictive Value for Chronic Complications.

作者信息

Gu Ping, Yu Dan, Zhang Yu, Chai Xiaoying

机构信息

Department of Endocrinology, Affiliated Hospital of Jiangnan University, Wuxi, People's Republic of China.

出版信息

Diabetes Metab Syndr Obes. 2025 Sep 4;18:3237-3247. doi: 10.2147/DMSO.S542183. eCollection 2025.

Abstract

PURPOSE

This study aims to explore the clinical significance of miR-17-5p in T2DM and its chronic complications.

PATIENTS AND METHODS

A total of 100 patients with T2DM and 90 healthy controls were included. The expression of miR-17-5p was detected by reverse transcription-polymerase chain reaction. A receiver operating characteristic curve was plotted to evaluate the diagnostic value of miR-17-5p for T2DM. Pearson correlation analysis was used to explore the correlation between miR-17-5p and blood glucose indicators in T2DM patients. The Kaplan-Meier curve and multivariate Cox regression analysis were employed to analyze the factors influencing chronic complications. Liposome-mediated transfection technology was used to transfect miR-17-5p mimics and inhibitors into endothelial progenitor cells (EPCs) respectively, to achieve overexpression and knockdown of miR-17-5p in cells. On this basis, we further investigate the potential molecular mechanism by which miR-17-5p is involved in the occurrence and development of chronic complications inT2DM.

RESULTS

Serum miR-17-5p was significantly downregulated in T2DM patients (vs healthy controls, P<0.001). The AUC for distinguishing T2DM patients from healthy individuals was 0.932. The expression of this miRNA was significantly negatively correlated with FBG (r=-0.718) and HbA1c (r=-0.695) (P<0.001). Follow-up showed that low expression of miR-17-5p was closely associated with T2DM chronic complications (complication group vs non-complication group, P<0.001), with an AUC of 0.866 for distinguishing the presence from the absence of complications. Kaplan-Meier analysis indicated that individuals with low miR-17-5p expression had a higher risk of complications (Log-rank P=0.009). Mechanistically, miR-17-5p targets FBXO48 and affects the functions of EPCs.

CONCLUSION

The expression of miR-17-5p is reduced in T2DM. It influences the functions of EPCs by targeting , and may be involved in the occurrence and development of chronic complications of T2DM.

摘要

目的

本研究旨在探讨miR-17-5p在2型糖尿病(T2DM)及其慢性并发症中的临床意义。

患者与方法

共纳入100例T2DM患者和90例健康对照者。采用逆转录-聚合酶链反应检测miR-17-5p的表达。绘制受试者工作特征曲线以评估miR-17-5p对T2DM的诊断价值。采用Pearson相关分析探讨T2DM患者中miR-17-5p与血糖指标之间的相关性。采用Kaplan-Meier曲线和多因素Cox回归分析来分析影响慢性并发症的因素。利用脂质体介导的转染技术分别将miR-17-5p模拟物和抑制剂转染至内皮祖细胞(EPCs)中,以实现细胞中miR-17-5p的过表达和敲低。在此基础上,我们进一步研究miR-17-5p参与T2DM慢性并发症发生发展的潜在分子机制。

结果

T2DM患者血清miR-17-5p显著下调(与健康对照者相比,P<0.001)。区分T2DM患者与健康个体的曲线下面积(AUC)为0.932。该微小RNA的表达与空腹血糖(FBG,r=-0.718)和糖化血红蛋白(HbA1c,r=-0.695)显著负相关(P<~0.001)。随访显示,miR-17-5p低表达与T2DM慢性并发症密切相关(并发症组与无并发症组相比,P<0.001),区分有无并发症的AUC为0.866。Kaplan-Meier分析表明,miR-17-5p低表达个体发生并发症的风险更高(对数秩检验P=0.009)。机制上,miR-17-5p靶向FBXO48并影响EPCs的功能。

结论

T2DM中miR-17-5p表达降低。它通过靶向作用影响EPCs的功能,可能参与T2DM慢性并发症的发生发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82e7/12417209/e2d91a403753/DMSO-18-3237-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验